HomeCompareTBIO vs ADC

TBIO vs ADC: Dividend Comparison 2026

TBIO yields 3921.57% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TBIO wins by $5928317923791.95M in total portfolio value
10 years
TBIO
TBIO
● Live price
3921.57%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5928317923792.13M
Annual income
$5,645,144,171,791,441,000.00
Full TBIO calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — TBIO vs ADC

📍 TBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTBIOADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TBIO + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TBIO pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TBIO
Annual income on $10K today (after 15% tax)
$333,333.33/yr
After 10yr DRIP, annual income (after tax)
$4,798,372,546,022,725,000.00/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, TBIO beats the other by $4,798,372,546,022,656,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TBIO + ADC for your $10,000?

TBIO: 50%ADC: 50%
100% ADC50/50100% TBIO
Portfolio after 10yr
$2964158961896.15M
Annual income
$2,822,572,085,895,761,000.00/yr
Blended yield
95.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

TBIO
Analyst Ratings
8
Buy
6
Hold
Consensus: Buy
Altman Z
-15.6
Piotroski
3/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TBIO buys
0
ADC buys
0
No recent congressional trades found for TBIO or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTBIOADC
Forward yield3921.57%4.13%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$5928317923792.13M$178.9K
Annual income after 10y$5,645,144,171,791,441,000.00$80,797.29
Total dividends collected$5908985646403.93M$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: TBIO vs ADC ($10,000, DRIP)

YearTBIO PortfolioTBIO Income/yrADC PortfolioADC Income/yrGap
1← crossover$402,857$392,156.86$10,990$580.36+$391.9KTBIO
2$15,195,831$14,764,774.15$12,301$860.26+$15.18MTBIO
3$536,754,727$520,495,188.22$14,104$1,298.62+$536.74MTBIO
4$17,756,748,906$17,182,421,348.17$16,691$2,008.16+$17756.73MTBIO
5$550,236,533,968$531,236,812,638.47$20,580$3,205.09+$550236.51MTBIO
6$15,973,499,921,404$15,384,746,830,057.32$26,754$5,330.02+$15973499.89MTBIO
7$434,496,251,181,035$417,404,606,265,133.20$37,196$9,345.14+$434496251.14MTBIO
8$11,075,986,607,305,350$10,611,075,618,541,642.00$56,244$17,523.09+$11075986607.25MTBIO
9$264,648,366,355,783,070$252,797,060,685,966,340.00$94,286$35,736.21+$264648366355.69MTBIO
10$5,928,317,923,792,128,000$5,645,144,171,791,441,000.00$178,949$80,797.29+$5928317923791.95MTBIO

TBIO vs ADC: Complete Analysis 2026

TBIOStock

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

Full TBIO Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this TBIO vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TBIO vs SCHDTBIO vs JEPITBIO vs OTBIO vs KOTBIO vs MAINTBIO vs NNNTBIO vs EPRTTBIO vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.